It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Respiratory viral (RV) infections represent a major threat for human health worldwide. Persons with HIV (PWH) have a compromised immune response and are thought to be at higher risk for severe RV disease. However, very little is known about the host immune response to RV infection in PWH. Here, we investigated gene expression changes in the peripheral blood of PWH co-infected with RV. Only very few differentially expressed genes could be detected between PWH with and without RV infection, suggesting that the immune response to RV in PWH is strongly dampened. Our data provides important insights into the host response to RV infections in HIV patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of North Carolina at Chapel Hill, Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
2 University of North Carolina at Chapel Hill, Department of Genetics, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208); University of North Carolina at Chapel Hill, Department of Microbiology and Immunology, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208); University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720)
3 Helmholtz Centre for Infection Research, Department of Infection Genetics, Brunswick, Germany (GRID:grid.7490.a) (ISNI:0000 0001 2238 295X); University of Veterinary Medicine Hannover, Hannover, Germany (GRID:grid.412970.9) (ISNI:0000 0001 0126 6191); University of Tennessee Health Science Center, Department of Microbiology, Immunology and Biochemistry, Memphis, USA (GRID:grid.267301.1) (ISNI:0000 0004 0386 9246)